Literature DB >> 7318897

Inhibition of gastric functions by stimulation of rat locus coeruleus.

Y Osumi, T Ishikawa, Y Okuma, Y Nagasaka, M Fujiwara.   

Abstract

To investigate the possible role of central noradrenergic neurons in the regulation of gastric functions, electrical stimulation of the locus coeruleus [LC] and microinjection of noradrenaline [NA] into the ala cinerea (area of the dorsal motor nucleus of the vagi [NDV] and the nucleus tractus solitarius [NTS]) were given to urethane-anesthetized rats. Unilateral electrical stimulation of the LC decreased both the basal levels and the lateral hypothalamic area [LHA]-induced increases in gastric acid output and mucosal blood flow. Microinjection of NA 0.1 and 0.5 micrograms/animal into the ala cinerea also decreased the basal levels of these gastric parameters. From these results, combined with neuroanatomical data from the literature, it is concluded that central noradrenergic inhibitory mechanisms originating from the LC seem to be involved in the regulation of gastric functions, probably at the level of the brain-stem ala cinerea.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318897     DOI: 10.1016/0014-2999(81)90341-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Stimulation of central alpha-2 adrenoceptors inhibits gastric secretion in rats by releasing vasopressin.

Authors:  J Puurunen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

2.  Ultrastructural evidence for selective noradrenergic innervation of CNS vagal projections to the fundus of the rat.

Authors:  Rebecca J Pearson; Philip J Gatti; Niaz Sahibzada; V John Massari; Richard A Gillis
Journal:  Auton Neurosci       Date:  2007-06-14       Impact factor: 3.145

3.  Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats.

Authors:  R G Pendleton; M Williams; C Chung; P Cook; E Risley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.